Palabras clave
garantía de la calidad de atención de salud
calidad de la atención de salud
enfermedades renales
Cómo citar
Resumen
Las vías clínicas son instrumentos desarrollados para planificar y coordinar la secuencia de procedimientos clínicos y administrativos necesarios para conseguir la máxima calidad asistencial. Su rápida difusión en EE. UU. explica que más del 60% de los hospitales usen vías clínicas para sus procesos más frecuentes. Esto contrasta con su escasa implementación en Colombia y los países de la Región de las Américas. Las Vías Clínicas se ajustan con el cambio que representa el enfoque en procesos, orientado a optimizar una mejor atención al paciente.
Citas
Saturno Hernández P. Cómo lograr la excelencia en la atención sanitaria. Construcción, implementación y evaluación de Vías Clínicas. Cuernavaca: Instituto Nacional de Salud Pública; 2018.
Saturno Hernández P. Métodos y herramientas para la realización de ciclos de mejora dela calidad en servicios de salud. Cuernavaca: Instituto Nacional de Salud Pública; 2015.
Ibeas J, Roca-Teyb R, Vallespínc J, Morenod T, Moñuxe G, Martí-Monrós A,et al. GuíaClínica Española del Acceso Vascular para Hemodiálisis. Nefrología. 2017;37(Suppl 1):1-192.https://dx.doi.org/10.1016/j.nefro.2017.11.004
Sou V, McManus C, Miin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for themanagement of dicult venous access. BMC Nurs. 2017;16:64. https://dx.doi.org/10.1186/s12912-017-0261-z
Padilla-Galindo H, Serrano A, Polo A, García R, Acosta J, Navarro-Micr E,et al.Caracte-rización clínica-epidemiológica de las glomerulonefritis primarias un centro de referenciade caribe colombiano, en niños menores de 15 años, de enero 2008 a diciembre 2013. Rev.Colomb. Nefrol. 2014;1(Suppl 1).
Colombia. Ministerio de Salud y Protección Social (MinSalud). Guía de Práctica Clínicapara el diagnóstico y tratamiento de la Enfermedad Renal Crónica (adopción). Bogotá D.C.:MinSalud; 2016 [citado mayo 19 2021]. Disponible en: http://gpc.minsalud.gov.co/gpcsites/Repositorio/Otrosconv/GPCerenal/gpcerenal.aspx
Every NR, Hochman J, Becker R, Kopecky S, Cannon CP. Critical Pathways: a review. Com-mittee on Acute Cardiac Care, Council on Clinical Cardiology, American Heart Association.Circulation. 2000;101(4):461-5. https://dx.doi.org/10.1161/01.cir.101.4.461
Carrasco G, Ferrer J. Las vías clínicas basadas en la evidencia como estrategia para la mejo-ra de la calidad: metodología, ventajas y limitaciones. Rev. Calid. Asist. 2001;16(3):199-207.https://dx.doi.org/10.1016/S1134-282X(01)77405-2.
Zander KS, Bower KA, Etheredge MLS. Nursing Case Management: Blueprints for Trans-formation. Boston: New England Medical Center Hospitals; 1987
The National Institute for Health and Care Excellence (NICE). Kidney con-ditions overview. Londres: NICE; 2018 [citado mayo 24 2021]. Disponible en:https://pathways.nice.org.uk/pathways/kidney-conditions#content=view-node%3Anodes-autosomal-dominant-polycystic-kidney-disease.
University of Calgary. Chronic Kidney Disease Clinical Pathway. Calgary: University ofCalgary; 2020 [citado mayo 24 2021]. Disponible en: http://www.ckdpathway.ca/
Interdisciplinary Chronic Disease Collaboration & Southern Alberta Renal Program.Chronic Kidney Disease (CKD) Clinical Pathway. 2020 [citado mayo 24 2021]. Disponibleen: http://www.ckdpathway.ca/aboutthepathway
Navarro-Bermúdez M. Desarrollo e implementación de una vía clínica a los pacientes queinician la hemodiálisis de forma programada. Rev Soc Esp Enferm Nefrol. 2011;14(1):15-22
Genovese C, DE Belvis AG, Rinaldi M, Manno V, Squeri R, LA Fauci V, et al. Quality andmanagement care improvement of patients with chronic kidney disease: from data analy-sis to the denition of a targeted clinical pathway in an Italian Region. J Prev Med Hyg.2018;59(4):E305-10. https://dx.doi.org/10.15167/2421-4248/jpmh2018.59.4.999.
Colombia. Ministerio de Salud y Protección Social (MinSalud). Vía clínica para el tra-tamiento de hepatitis C crónica. Bogotá D.C.: MinSalud; 2017 [citado mayo 13 2021].Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/via-clinica-tratamiento-hepatitisc.pdf
Jimenez N, Aroca-Martínez G, Santos GD. Implementación de un modelo de salud renalen red informática para la temprana detección y cuidado de la nefropatía primaria lúpicay glomerulonefritis en la Región Caribe Colombiana. Rev. Colomb. Nefrol. 2014;1(Suppl 1).
Castillo-Parodi L, Navarro-Jiménez E, Arango-Quiroz Y, López-Avendaño A, Mejía-VarelaV, González-Torres HJ,et al. Obesity Association with Chronic Renal Disease in Patientsattended at Clínica de la Costa. Barranquilla, Colombia. 2005-2014. Rev. Colomb. Nefrol.2021;3(1):14-9. https://doi.org/10.22265/acnef.3.1.217
Genovese C, DE Belvis AG, Rinaldi M, Manno V, Squeri R, LA Fauci V,et al.Quality andmanagement care improvement of patients with chronic kidney disease: from data analy-sis to the denition of a targeted clinical pathway in an Italian Region. J Prev Med Hyg.2018;59(4):E305-10. https://dx.doi.org/10.15167/2421-4248/jpmh2018.59.4.999
Childrens Hospital Colorado. Venous thromboembolism (VTE) prevention. Clinical pathway; 2020 [citado mayo 24 de 2021]. Disponible en: https://www.childrenscolorado.org/4adc94/globalassets/healthcare-professionals/clinical-pathways/venous-thromboembolism.pdf
Canadá. Ministry of Health and Long-Term Care. Quality-Based Procedures ClinicalHandbook for Chronic Kidney Disease Ontario: Ministry of Health and Long-Term Care;2016 [citado mayo 24 2021]. Disponible en: http://www.health.gov.on.ca/en/pro/programs/ecfa/docs/qbpkidney.pdf
Curtis C, Balint C, Al Hamarneh YN, Donald M, Tsuyuki RT, McBrien K,et al. Onli-ne clinical pathway for managing adults with chronic kidney disease. Can Pharm J (Ott).2015;148(5):257-62. https://doi.org/10.1177/1715163515597243.
Donald M, McBrien K, Jackson W, Manns BJ, Tonelli M, King-Shier K,et al. Develop-ment and implementation of an online clinical pathway for adult chronic kidney disea-se in primary care: a mixed methods study. BMC Med Inform Decis Mak. 2016;16:109.https://doi.org/10.1186/s12911-016-0350-z
Gruber-Baldini AL, Velozo C, Romero S, Shulman LM. Validation of the PROMIS®mea-sures of self-ecacy for managing chronic conditions. Qual. Life Res. 2017;26(7):1915-24.https://doi.org/10.1007/s11136-017-1527-3.
Johnson ML, Zimmerman L, Welch JL, Hertzog M, Pozehl B, Plumb T. Patient activationwith knowledge, self-management and condence in chronic kidney disease. J Ren Care.2016;42(1):15-22. https://doi.org/10.1111/jorc.12142.
Ploeg J, Matthew-Maich N, Fraser K, Dufour S, McAiney C, Kaasalainen S,et al. Managingmultiple chronic conditions in the community: a Canadianqualitative study of the experien-ces of older adults, family caregivers and healthcare providers. BMC Geriatr. 2017;17(1):40.https://doi.org/10.1186/s12877-017-0431-6.
Dobkowski D, Zuber K, Davis J. Updated guidelines for managing chronic kidney disease.JAAPA. 2013;26(11):27-31. https://doi.org/10.1097/01.JAA.0000436686.98552.56.
Post FA. Managing chronic kidney disease in the older adults living with HIV. Curr OpinInfect Dis. 2017;30(1):4-11. https://doi.org/10.1097/QCO.0000000000000333.
Coyne E, Langham H, Tomlin M, Hope W, Johnson C, Byrne C,et al. Young adults withchronic kidney disease: An exploration of their relationships and support networks. J RenCare. 2019;45(1):20-8. https://doi.org/10.1111/jorc.12263.
Toy JM, Drechsler A, Waters RC. Clinical pathways for primary care: current use, interestand perceived usability. J Am Med Inform Assoc. 2018;25(7):901-6. https://doi.org/10.1093/jamia/ocy010
Grimsmo A, Løhre A, Røsstad T, Gjerde I, Heiberg I, Steinsbekk A. Disease- specic cli-nical pathways - are they feasible in primary care? A mixed-methods study. Scand J PrimHealth Care. 2018;36(2):152-60. https://doi.org/10.1080/02813432.2018.1459167.
Mejia C, Libby BA, Bracken ML, Shanley B, Holovatska MM, Wanik J,et al.Interest inDigital Dietary Support Among Adults With Kidney Failure Receiving Hemodialysis. J RenNutr. 2020;31(3):327-32. https://doi.org/10.1053/j.jrn.2020.06.004.
Harwood L, Clark AM. Dialysis modality decision-making for older adults with chronickidney disease. J Clin Nurs. 2014;23(23-24):3378-90. https://doi.org/10.1111/jocn.12582.
Tam-Tham H, Hemmelgarn BR, Campbell DJ, Thomas CM, Fruetel K, Quinn RR,et al. Pri-mary care physicians’ perceived barriers, facilitators and strategies to enhance conservativecare for older adults with chronic kidney disease: a qualitative descriptive study. NephrolDial Transplant. 2016;31(11):1864-70. https://doi.org/10.1093/ndt/gfv408.
Tahir M, Hassan S, de Lusignan S, Shaheen L, Chan T, Dmitrieva O. Developmentof a questionnaire to evaluate practitioners’ condence and knowledge in primary ca-re in managing chronic kidney disease. BMC Nephrol. 2014;15:73. https://doi.org/10.1186/1471-2369-15-73.
Owen JE, Walker RJ, Edgell L, Collie J, Douglas L, Hewitson TD,et al. Implementationof a pre-dialysis clinical pathway for patients with chronic kidney disease. Int J Qual HealCare. 2006;18(2):145-51. https://doi.org/10.1093/intqhc/mzi094
Tsuyuki RT. Rearming our focus on patient-centred care. Can Pharm J (Ott).2015;148(5):225-6. https://doi.org/10.1177/1715163515599963.
Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C,et al. Perceived Be-nets and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disea-se Care: A Qualitative Descriptive Study. Can J Kidney Health Dis. 2018;5:205435811876380.https://doi.org/10.1177/2054358118763809.
Geense WW, van Gaal BG, Knoll JL, Cornelissen EA, Schoonhoven L, Kok G. OnlineSupport Program for Parents of Children With a Chronic Kidney Disease Using InterventionMapping: A Development and Evaluation Protocol. JMIR Res. Protoc. 2016;5(1):e1. https://doi.org/10.2196/resprot.4837
Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr,et al. Clinical practiceguidelines for managing dyslipidemias in kidney transplant patients: a report from the Ma-naging Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foun-dation Kidney Disease Outcomes Quality Initiative. Am J Transplant. 2004;4(Suppl 7):13-53.https://doi.org/10.1111/j.1600-6135.2004.0355.x.
Lovre D., Shah S, Sihota A, Fonseca VA. Managing Diabetes and Cardiovascular Riskin Chronic Kidney Disease Patients. Endocrinol Metab Clin North Am. 2018;47(1):237-57.https://doi.org/10.1016/j.ecl.2017.10.006
Zac-Varghese S, Winocour P. Managing diabetic kidney disease. Br Med Bull.2018;125(1):55-66. https://doi.org/10.1093/bmb/ldx047
Clemens KK, O’Regan N, Rhee JJ. Diabetes Management in Older Adults With Chro-nic Kidney Disease. Curr Diab Rep. 2019;19(3):11. https://doi.org/10.1007/s11892-019-1128-3
Lo C, Zimbudzi E, Teede H, Cass A, Fulcher G, Gallagher M,et al. Models of care for co-morbid diabetes and chronic kidney disease. Nephrology (Carlton). 2018;23(8):711-7. https://doi.org/10.1111/nep.13232
Fitzpatrick A, Mohammadi F, Jesudason S. Managing pregnancy in chronic kidney di-sease: improving outcomes for mother and baby. Int J Womens Health. 2016;8:273-85.https://doi.org/10.2147/IJWH.S76819
Wiles K, Chappell L, Clark K, Elman L, Hall M, Lightstone L,et al.Clinical practice guide-line on pregnancy and renal disease. BMC Nephrol. 2019;20(1):401. https://doi.org/10.1186/s12882-019-1560-2
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.